Lower serum paraoxonase-1 activity in type 2 diabetic patients correlates with nitrated apolipoprotein A-I levels
Authors:
- Alejandro GugliucciAGAlejandro Gugliucci
- 1 June 2006
- journal article
- other
- Published by Elsevier in Clinica Chimica Acta
- Vol. 368 (1-2) , 201-202
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: Relevance to diabetesAtherosclerosis, 2006
- Paraoxonases and cardiovascular diseases: pharmacological and nutritional influencesCurrent Opinion in Lipidology, 2005
- Circulating levels of nitrated apolipoprotein A-I are increased in type 2 diabetic patientsClinical Chemistry and Laboratory Medicine (CCLM), 2005
- High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular diseaseCurrent Opinion in Lipidology, 2004
- Role of Hyperglycemia in Nitrotyrosine Postprandial GenerationDiabetes Care, 2002
- Low paraoxonase activity in type II diabetes mellitus complicated by retinopathyClinical Science, 2000